Chinese pharmaceutical company Harbin Gloria Pharmaceuticals intends to issue medium-term notes due 2019 in a public offering to raise CNY1.6bn ($243.13m).

F. Hoffmann-La Roche (Roche) and Warp Drive Bio have formed a partnership to deploy the latter’s genome mining platform to develop antibiotics for bacterial infections.

Warp Drive Bio will receive an upfront payment of $87m and up to $300m in milestone payments for sales on products licensed to Roche

Roche is a Switzerland-based pharmaceutical company, while Warp Drive Bio is a drug discovery company based in the US.

“F. Hoffmann-La Roche (Roche) and Warp Drive Bio have formed a partnership to deploy the latter’s genome mining platform to develop antibiotics for bacterial infections.”

US-based biotechnology company Intrexon plans to raise $100m through the private placement of one million series A redeemable preferred stock priced at $100 a share.

Opiant Pharmaceuticals plans to raise $150m through a public offering of common stock and warrants.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The US-based pharmaceutical company plans to use the funds for general corporate purposes.

Lipocine plans to issue shares of its common stock in a public offering to raise $25m.

The US-based pharmaceutical firm plans to use the funds towards general corporate purposes.

Pharmaceutical Technology Excellence Awards - Have you nominated?

Nominations are now open for the prestigious Pharmaceutical Technology Excellence Awards - one of the industry's most recognised programmes celebrating innovation, leadership, and impact. This is your chance to showcase your achievements, highlight industry advancements, and gain global recognition. Don't miss the opportunity to be honoured among the best - submit your nomination today!

Nominate Now